Where's the A/S increase filing?

If there is one please link me!

Any shareholders get rich during the past several years by investing in CBAI stock?

Mmmmmmmmmm Nope!

Matt is constantly begging JMJ for money.

JMJ already holds CBAI's assets. JMJ will always control CBAI.

If TDA is allowing buys then the chill might really be removed.

How much has CBAI paid to lenders in chill fees? More than $1,000,000.00? Ouch! That's gotta hurt!

I still think CBAI will decline to sub penny. I truly think there is another major bad news event on the way.

You having trouble confirming that un-quoted PR too?

Any forger could have cut and pasted that "CONTACT:Paul Knopick E & E Communications 949/707-5365 pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc." the same way you just did.

Let's see if Matt will confirm or deny the authenticity of that chill removal PR in the morning.

Where's Knopick (CBAI Investor Relations guy)?

Any ideas why he hasn't posted on this board about the big Chill Removal PR?

Will he go on record publicly confirming the "chill" removal?

Just hope that Chill Removal PR is genuine, if not, trading will probably be immediately suspended.

No direct quote from Matt on the chill removal?

Can anyone independently confirm the chill has been removed?

It wouldn't be the first time in history a desperate shareholder plugged into a newswire service and posted a fraudulent PR.

Yep, the CMEX LOI is dead. The amendment with CCEL and CMEX proves it.

That puts the "Matt has never failed to close a LOI" rhetoric to rest.

Makes me wonder if CBAI is in arrears on any of their regular monthly bills.

LOL! Yep, they might evaluate a strategy at some point in time but don't exactly know when and with whom but "Stay Tuned".

Wow! Looks like CBAI is in bad shape.

Also looks like somebody told them to cool it on the pumperish no detail PR's like the 3 LOI 8-Ks and PR's.

BK filing? Reuters 10/12/11 10:20am:

"Cord Blood America Inc to evaluate possible strategic alternatives"

No additional information provided.

Shills were making trades coinciding with that fake Schissler's post. The fake Schissler and the shill traders making the trades were all in it together.

Somebody is getting very desperate and stupid.

Is the facility accredited by the American Association of Blood Banks?


7 Smart Questions to Ask a Cord-Blood Bank
Obviously, price and a compelling Web site aren't the only factors to consider when choosing a bank. Be sure to do your homework before signing up.


Is the facility accredited by the American Association of Blood Banks? This means its labs, banks, and procedures meet set standards.

How long has the company been in business? At least five years is best.

How many units does it store? Look for a bank that has thousands.

How many successful transplants have been performed with its stored samples? Having at least one demonstrates that its process works, but two or three is better.

Is the blood stored as a single unit or in several samples? Freezing in portions is preferred so the blood can be tested for potential transplant use without thawing -- and wasting -- the entire sample.

Is the company private or publicly held? If it's a publicly traded company, you'll have the advantage of reviewing its financials. Many banks are part of larger biotech companies.

Is the storage fee fixed or subject to increases? You want to know the total price tag up front.

http://www.parents.com/pregnancy/my-baby/cord-blood-banking/the-cord-blood-controversy/?page=4

"the majority of all cord blood stored in private banks may be unusable"

What Banks Don't Tell Parents

While cord-blood companies herald the possible future treatments of many adult diseases with stem cells, they rarely mention a key issue. Researchers have greater hopes for the potential of embryonic stem cells, which are thought to have the ability to develop into many different types of cells. It is not known whether the stem cells in cord blood have that ability; until recently, it was thought that they (like those in bone marrow) could only regenerate blood and immune cells.

What's more, few cord-blood transplants have been given to adults because most units haven't contained enough stem cells to treat anyone weighing more than 90 pounds, says Joanne Kurtzberg, MD, program director of the division of pediatric blood and marrow transplantation at Duke University Medical Center. And since the procedure is relatively new, no one knows how many years the frozen units will remain viable.

In fact, the shocking truth is that the majority of all cord blood stored in private banks may be unusable. Approximately 75 percent of the units donated to public banks are discarded or used in research because they don't contain enough stem cells for transplants, says Mary Halet, manager of cord-blood operations for the Center for Cord Blood at the National Marrow Donor Program, a Minneapolis-based nonprofit organization that maintains the nation's largest public supply of cord blood. Yet private banks store every unit they collect, which means that you might pay to store blood that won't be usable if you need it years later.

And as Victor and Tracey Dones learned, a child's own cord blood can't always be used to treat him, even when he's young. "Childhood leukemia is one of the diseases private banks like to play up, but most kids with leukemia are cured with chemotherapy alone. If a transplant is needed, we wouldn't use a child's tainted cord blood," Dr. Kurtzberg says.

It would be possible for a healthy child's cord blood to be used to treat a sibling with leukemia, but the banks' literature doesn't spell out that distinction. In the last 10 years, almost all of the approximately 70 cord-blood transplants that have used privately stored blood were given to relatives with preexisting conditions, not to the donors themselves.

In fact, the AAP does encourage parents to keep their child's cord blood if a family member has already been diagnosed with a stem-cell-treatable disease. But a family won't have to foot the bill: The Children's Hospital Oakland Research Institute, in California, will bank a baby's cord blood for free if a family member needs it at the time of the baby's birth. Some private banks, such as Cord Blood Registry, Cryo-Cell, and ViaCord, have similar programs.

In 2007, the AAP issued a revised cord-blood-banking policy, that discourages private banks for families who aren't already facing a health crisis. "These banks prey on parents' fears of the unknown, and there's no scientific basis for a number of medical claims they make," says Bertram Lubin, MD, president and director of medical research for Children's Hospital Oakland Research Institute, and coauthor for the AAP's 2006 cord-blood-banking committee.

http://www.parents.com/pregnancy/my-baby/cord-blood-banking/the-cord-blood-controversy/?page=2

Italy and France have banned private cord-blood banking altogether

CLICK THE LINK AT BOTTOM TO READ ALL 4 PAGES

The Cord Blood Controversy

Given the chance to freeze their newborn's own stem cells, more and more expectant parents are signing up with pricey cord-blood banks. But could these cells really save your child's life someday?
By Jeannette Moninger

Insurance -- or Reassurance?

When Tracey and Victor Dones's 4-month-old son was diagnosed with osteopetrosis, a potentially fatal disorder that affects bone formation, the panic-stricken couple was relieved to hear that a stem-cell transplant could save his life. "We'd paid to store Anthony's umbilical-cord blood in a private bank in case he ever needed it -- and I thought we were so smart for having had the foresight to do that," says Tracey.

The Doneses were shocked, however, when doctors told them that Anthony's cord blood couldn't be used because the cells contained the same genetic defect that caused his condition. "The materials provided by the bank said this was Anthony's life insurance and could save him if he needed it. They never mentioned that the cells could be diseased. We felt duped," Tracey says. The Long Island, New York, couple has since filed a lawsuit against the bank alleging false advertising and consumer fraud.

They aren't the only ones questioning the business practices of private cord-blood banks. Both the American College of Obstetricians and Gynecologists (ACOG) and the American Academy of Pediatrics (AAP) issued statements in the late 1990s opposing the use of for-profit banks -- and criticizing their marketing tactics. Instead, they recommended that parents donate cord blood to public banks, which make it available for free to anyone who needs it. Globally, other organizations have done the same. Italy and France have banned private cord-blood banking altogether.

"Raising a family is expensive enough," says Jeffrey Ecker, MD, director of obstetrical clinical research at Massachusetts General Hospital, in Boston, and a member of ACOG's ethics committee. "There's no reason for parents to take on this additional financial burden when there's little chance of a child ever using his own cord blood."

Is It Right for Your Family?

Once considered medical waste, the blood left in the umbilical cord after a baby's delivery is now known to be a rich source of stem cells similar to those in bone marrow. It's been used in transplants to treat more than 70 different diseases including leukemia, lymphoma, sickle-cell disease, and some metabolic disorders. Unlike with marrow, which is obtained through a painful medical procedure and replenished by the body, there's only one chance to collect this seemingly magical elixir: immediately after a baby's birth.

Since the first successful sibling-to-sibling cord-blood stem-cell transplant was performed in 1988 to treat a genetic disorder called Fanconi's anemia, more than 20 private banks have opened. And they seem to have the address of every expectant couple in America -- whose mailboxes bulge with brochures encouraging them to take advantage of this once-in-a-lifetime opportunity. "Cord-blood banking is like insurance to protect your family against unforeseeable events," says Stephen Grant, cofounder and senior vice president of Cord Blood Registry, a large California-based private bank. "You do it out of love and responsibility for your family. Sure, you hope you'll never have to use the blood, but if you do, it'll be there."

Not surprisingly, this emotional pitch is working -- especially because the seemingly unlimited potential of stem cells has dominated the news in recent years. From 2003 to 2004, for example, the number of couples opting to use a private bank increased by 55 percent to 271,000. The three biggest companies -- who have the majority of the approximately $250 million market -- are vying for business.

Like any insurance, cord-blood banking isn't cheap. Banks initially charge from $1,000 to $2,000 to collect and process the stem-cell units, which are stored for a family's exclusive use. When you factor in additional costs for shipping (about $150 for a medical courier), the doctor's collection fee (prices can range from $150 to $500), and annual storage fees averaging $100 per year for 18 years, parents can expect to pay up to $4,000 in expenses not covered by insurance.

But considering the average cost of a new car or top-of-the-line stroller these days, many expectant parents feel it's not an unreasonable price to pay to give their child the best chance in life. "Ultimately, my conscience wouldn't let me not do it," says Merilee Kern, of San Diego. "We could afford it, and the blood could someday save my daughter."

Certainly, there are plenty of doctors who have high hopes for stem-cell advances and advise patients to consider cord-blood banking. When private banks first started sending him informational packets, Jordan Perlow, MD, a maternal-fetal specialist in Phoenix, assumed they were just trying to profit from parents' anxieties. But after attending medical conferences and scrutinizing studies about developments in stem-cell therapies, Dr. Perlow now encourages his patients to privately bank if they can afford it because he's convinced that it might save their child's life or the life of another family member. "If private banking had been available when my children were born, I would have done it," he says.

There are no hard numbers on a child's risk of needing a stem-cell transplant: It's anywhere between one in 1,000 and one in 200,000, according to studies cited by ACOG and the AAP. But private banks' marketing materials often place the odds at one in 2,700 and note that these numbers don't factor in its potential future use for diabetes, Alzheimer's, Parkinson's disease, and spinal-cord injuries in adults. "Researchers are constantly discovering new treatments using stem cells," says Gerald Maass, executive vice president of corporate development for Cryo-Cell, a private bank in Clearwater, Florida. Another major bank's Web site claims incredible odds: "Should cord blood prove successful in treating heart disease, the lifetime probability of being diagnosed with a disease treatable by cord blood will increase from one in 100 to one in two."

http://www.parents.com/pregnancy/my-baby/cord-blood-banking/the-cord-blood-controversy/

Matt could just as easily kept his mouth shut about the Cash Flow Positive thing and proven CBAI to be cash flow positive instead of "anticipating" it with a specific date of June 30, 2009 in a press release. But noooooooo, here CBAI sits (after a reverse split) at an all time historical low of .023. What does that tell you?

I wonder if any investors were mislead into buying the stock with that Cash Flow Positive statement?

Last post of the day.

You definitely WITNESSED it!

Cord Blood America Restructures Debt; Projects to be Cash Flow Positive
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced an agreement with Shelter Island Opportunity Fund to restructure its current outstanding debt. "The restructuring is a major step forward for Cord Blood America. With the signing of the agreement, Cord Blood America projects it will become cash flow positive for the first time in its history," said Matthew Schissler, Founder and CEO. "We anticipate formally being able to announce this when we file our quarterly numbers for period ending June 30, 2009."

"We have emphasized to our shareholders that reducing debt is a major focus in 2009," Mr. Schissler said. "This agreement provides us the opportunity to follow through on our commitment." The Company recently announced that since the beginning of 2009, it has reduced long term debt by more than $1 million. "The storage of stem cells is a predictable, high margin revenue stream business with little bad debt," Mr. Schissler continued. "The loan originally helped CBAI to acquire a large customer base with the CorCell acquisition, giving us consistent cash flow. The principals of Shelter Island Opportunity Fund worked with us to restructure our debt, putting us in position to run as a cash flow positive organization. This is a gesture of true partnering with CBAI, while sharing the stem cell vision to become a globally dominant stem cell storage company."

Mr. Schissler also stressed that the entire stem cell sector and its investors await the announcement from the Obama Administration lifting the current ban on Federal funding for research on embryonic stem cell lines. "Continued progress and potential additional discoveries in the use of stem cells in treating diabetes, heart disease, and other major diseases will dramatically increase the number of families storing umbilical cord blood stem cells, the focus of our business," Mr. Schissler said.

http://www.stemcellclinic.com/en/pr/item/335.html
-----------------------------------------------------------
The no need for a reverse split was in a interview and I will post it forthwith.

Glad you agree Matt has lied directly to a shareholder in person to their face.

Matt lied to a shareholder saying there would be no more dilution in January 2010 at the Grand Opening. You personally witnessed that lie right? Would you swear under oath the tell the truth the whole truth and nothing but the truth so help you God?

He lied about being cash flow positive right?

He lied about no need for a reverse split right?

I remember the CMEX LOI which by the way has expired a long time ago according to it's detailed written contractual language but I haven't seen the 2 no-name LOI's.

If those 2 no-name LOI's are contacted by the SEC to provide proof of the LOI's with CBAI, will there be any problems confirming the documentations?

In other words, will there be a signed and dated paper documention of those LOI's or were they just phone conversations?

Just asking your opinion, that's all.

They are already upside down on that 400,000 share "purchase".

I figured you'd give me that answer:

CMEX and 2 no-names? Yes, Now I remember !

What 3 LOI's? Name them.

Answer: Let me Dig them up and I"ll get Back with you later !

Shareholders NEVER sell/dump CBAI stock?

Answer: YES, shareholders do sell/dump CBAI stock

Agreed, so you do not beleive Paul was telling the truth about the UPLOAD and CORRESPONDENCE letters NOT being public information. Thank you.

Now on to the LOI's. Styxler said Paul personally told him over the phone that 1 of the LOI's was lost. Styxler did not say Paul said the LOI's (all of them) were lost. I agree with you on that one too!

Aren't the SEC filings made by CBAI part of the "messages" Paul gets paid for?

Paul, the "Paid Conduit of CBAI" also said the UPLOAD and CORRESPONDENCE letters from and to the SEC were NOT public information which is FALSE.

Do you still beleive that proven FALSE statement by Paul?

Do you beleive the UPLOAD and CORRESPONDENCE letters from and to the SEC are NOT public information?

Are the UPLOAD and CORRESPONDENCE letters from and to the SEC not part of CBAI's SEC filings and are merely Hearsay?

Pitiful.

SEC Staff to Publicly Release Comment Letters and Responses

"We will begin releasing our comment letters and response letters relating to disclosure filings made after August 1, 2004 that are selected for review."

http://www.sec.gov/news/press/2004-89.htm

I will post the UPLOAD and CORRESPOBDENCE letters from and to the SEC (4/23/2010 to present) by way of the Freedom Of Information Act unless they are exempted for these nine reasons:

Freedom of Information Act Exemptions

The Freedom of Information Act entitles the following exemptions on documents being requested by the public:

1. Those documents properly classified as secret in the interest of national defense or foreign policy;

2. Related solely to internal personnel rules and practices;

3. Specifically exempted by other statutes;

4. A trade secret or privileged or confidential commercial or financial information obtained from a person;

5. A privileged inter-agency or intra-agency memorandum or letter;

6. A personnel, medical, or similar file the release of which would constitute a clearly unwarranted invasion of personal privacy;

7. Compiled for law enforcement purposes, the release of which

a. could reasonably be expected to interfere with law enforcement proceedings,

b. would deprive a person of a right to a fair trial or an impartial adjudication,

c. could reasonably be expected to constitute an unwarranted invasion of personal privacy,

d. could reasonably be expected to disclose the identity of a confidential source,

e. would disclose techniques, procedures, or guidelines for investigations or prosecutions, or

f. could reasonably be expected to endanger an individual's life or physical safety;

8. Contained in or related to examination, operating, or condition reports about financial institutions that the SEC regulates or supervises; or

9. And those documents containing exempt information about gas or oil wells.

http://www.sec.gov/foia/nfoia.htm

Why no Form UPLOAD-SEC generated letter filing?

The last UPLOAD filing was on 04/23/2010.
http://www.sec.gov/Archives/edgar/data/1289496/000000000010022416/filename1.pdf
Why haven't the UPLOAD letters from the SEC and CORRESPONDENCE letters from CBAI to the SEC not been filed?

Dilution + chill picture becoming clearer = sub .01

IMO

41,228,566 shares of dilution in 3 months?

"Number of shares of Cord Blood America, Inc. common stock, $0.0001 par value, outstanding as of June 30, 2011, 70,895,400 exclusive of treasury shares."